SaluTech
New York
About SaluTech
SaluTech develops a conductive biomaterial (CBM) to treat the underlying cause of the arrhythmia. This CBM has the ability to reduce/diminish arrhythmia while being nontoxic, biocompatible, and inexpensive to produce.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Jan 2019)
- Website: salutechlimited.com
Industries & Categories
Biotechnology, Health Care, Medical, Wellness
Canonical: https://fsome.com/organization/salutech-2674760 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.